Unintended negative consequences of genetically engineered organisms are already being felt around the world. Adequate provisions for liability and compensation are needed in the Biosafety Protocol to create incentives for responsible corporate behavior, and to create disincentives for premature releases of GMOs that have been inadequately tested for the effects on biodiversity and human health.